ArticleEBioMedicine2020

Corrigendum to 'Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer' [EBioMedicine 38 (2018) 100-112].

Pinar Kanlikilicer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.